Archives of Medical Science (Jan 2024)

Obesity and lung cancer – is programmed death ligand-1 (PD-1L) expression a connection?

  • Jakub Krzysztof Gałązka,
  • Marcin Czeczelewski,
  • Tomasz Kucharczyk,
  • Katarzyna Szklener,
  • Sławomir Mańdziuk

DOI
https://doi.org/10.5114/aoms/175470
Journal volume & issue
Vol. 20, no. 1
pp. 313 – 316

Abstract

Read online

Introduction In this retrospective study, the authors evaluated whether obesity-induced immunomodulation impacts the expression of programmed death ligand-1 (PD-1L) in lung cancer cells. Methods A retrospective cross-sectional study was performed. The study included 67 patients. The data did not have a normal distribution. Results For women, using ANOVA test (p = 0.050) with post-hoc analysis, a statistically significant difference in expression was found between women with overweight and women with normal weight (p = 0.040). Conclusions Apart from the above, the authors did not find any statistically significant correlation between PD-1L expression on lung cancer cells and body mass index, either in the whole group or in histological subgroups.

Keywords